Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Notes Payables: 2019-2025

Historic Notes Payables for Rockwell Medical (RMTI) over the last 5 years, with Sep 2025 value amounting to $462,000.

  • Rockwell Medical's Notes Payables fell 1.49% to $462,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $462,000, marking a year-over-year decrease of 1.49%. This contributed to the annual value of $268,000 for FY2024, which is 9.84% up from last year.
  • Rockwell Medical's Notes Payables amounted to $462,000 in Q3 2025, which was down 30.00% from $660,000 recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Notes Payables ranged from a high of $1.5 million in Q2 2022 and a low of $67,000 during Q1 2025.
  • Its 3-year average for Notes Payables is $451,222, with a median of $469,000 in 2024.
  • Its Notes Payables has fluctuated over the past 5 years, first climbed by 15.10% in 2022, then plummeted by 51.49% in 2023.
  • Over the past 5 years, Rockwell Medical's Notes Payables (Quarterly) stood at $437,000 in 2021, then increased by 15.10% to $503,000 in 2022, then plummeted by 51.49% to $244,000 in 2023, then climbed by 9.84% to $268,000 in 2024, then decreased by 1.49% to $462,000 in 2025.
  • Its Notes Payables was $462,000 in Q3 2025, compared to $660,000 in Q2 2025 and $67,000 in Q1 2025.